{
    "2019-03-29": [
        [
            {
                "time": "",
                "orginal_text": "再增9家，28家企业已获科创板“准考证”！新成员全透视+影子股一览",
                "features": {
                    "keywords": [
                        "科创板",
                        "企业",
                        "准考证",
                        "影子股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "orginal_text": "【天风医药】上海医药：行业变革带来商业生态重构机遇，龙头优势凸显",
                "features": {
                    "keywords": [
                        "上海医药",
                        "行业变革",
                        "商业生态",
                        "龙头优势"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "医疗保健：辞旧迎新 2019年1月建议选择性布局优质个股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "2019年1月",
                        "优质个股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "orginal_text": "29日公司新闻聚焦：贵州茅台拟10派145元",
                "features": {
                    "keywords": [
                        "贵州茅台",
                        "分红",
                        "10派145元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "牛市早报｜一季度A股行情今日收官，科创板受理企业又增两家",
                "features": {
                    "keywords": [
                        "A股",
                        "一季度",
                        "科创板",
                        "新增企业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "orginal_text": "面临破位还需两手准备",
                "features": {
                    "keywords": [
                        "破位",
                        "两手准备"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "上海医药去年净利38.81亿元 同比增长10% 董事长周军未在公司领取报酬",
                "features": {
                    "keywords": [
                        "上海医药",
                        "净利润",
                        "同比增长",
                        "董事长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}